GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Total Equity

Iran Daru (XTEH:IRDR1) Total Equity : IRR0.00 Mil (As of . 20)


View and export this data going back to 1990. Start your Free Trial

What is Iran Daru Total Equity?

Iran Daru's total equity for the quarter that ended in . 20 was IRR0.00 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Iran Daru Total Equity Historical Data

The historical data trend for Iran Daru's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Iran Daru Total Equity Chart

Iran Daru Annual Data
Trend
Total Equity

Iran Daru Semi-Annual Data
Total Equity

Iran Daru Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Iran Daru's Total Equity for the fiscal year that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

Iran Daru's Total Equity for the quarter that ended in . 20 is calculated as

Total Equity=Total Assets(Q: . 20 )-Total Liabilities(Q: . 20 )
=N/A-N/A
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Iran Daru Total Equity Related Terms

Thank you for viewing the detailed overview of Iran Daru's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Iran Daru (XTEH:IRDR1) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Iran Daru (XTEH:IRDR1) » Definitions » Total Equity
Comparable Companies
Traded in Other Exchanges
N/A
Address
Ayatollah Saeedi Highway, End Of Kermani Street, Moallem Boulevard, Tehran, IRN, 1371658111
Website
https://www.irandaru.com
Iran Daru is a pharmaceutical company based in Iran. It manufactures and sells pharmaceutical products for antibiotics, cardiovascular agents, and local anesthetic agents. The company manufactures products in three main dosage form categories namely solid, semi-solid, and liquid including tablets, capsules, pellets, sachets, gels, creams, ointments (sterile and non-sterile), spray solutions, and syrups. Products offered by Iran Daru include Diclofenac Potassium, Biotin 5 mg, Tetracycline, Folic acid, Meloxicam, Acetaminophen and Caffeine, and Levocetirizine dihydrochloride, among others. It also exports its products to other countries.

Iran Daru (XTEH:IRDR1) Headlines

No Headlines